Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center
- PMID: 35528980
- PMCID: PMC9039699
- DOI: 10.14218/JCTH.2021.00188
Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center
Abstract
Background and aims: Vibration-controlled transient elastography (VCTE) is a noninvasive tool that uses liver stiffness measurement (LSM) to assess fibrosis. Since real-life data during everyday clinical practice in the USA are lacking, we describe the patterns of use and diagnostic performance of VCTE in patients at an academic medical center in New York City.
Methods: Patients who received VCTE scans were included if liver biopsy was performed within 1 year. Diagnostic performance of VCTE in differentiating dichotomized fibrosis stages was assessed via area under the receiver operating characteristics (AUROC). Fibrosis stage determined from VCTE LSM was compared to liver biopsy.
Results: Of 109 patients, 49 had nonalcoholic fatty liver disease, 16 chronic hepatitis C, 15 congestive hepatopathy, and 22 at least two etiologies. AUROC was 0.90 for differentiating cirrhosis (stage 4) with a positive predictive value (PPV) range of 0.28 to 0.45 and negative predictive value range of 0.96 to 0.98. For 31 (32%) patients, VCTE fibrosis stage was at least two stages higher than liver biopsy fibrosis stage. Thirteen of thirty-five patients considered to have cirrhosis by VCTE had stage 0 to 2 and 12 stage 3 fibrosis on liver biopsy.
Conclusions: VCTE has reasonable diagnostic accuracy and is reliable at ruling out cirrhosis. However, because of its low PPV, caution must be exercised when used to diagnose cirrhosis, as misdiagnosis can lead to unnecessary health care interventions. In routine practice, VTCE is also sometimes performed for disease etiologies for which it has not been robustly validated.
Keywords: Chronic liver disease; Cirrhosis; Hepatitis; Liver histopathology; Nonalcoholic fatty liver disease.
© 2022 Authors.
Conflict of interest statement
The authors have no conflict of interests related to this publication.
Figures



Similar articles
-
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.Clin Gastroenterol Hepatol. 2019 Jan;17(1):156-163.e2. doi: 10.1016/j.cgh.2018.04.043. Epub 2018 Apr 26. Clin Gastroenterol Hepatol. 2019. PMID: 29705261 Free PMC article.
-
Diagnostic Performance of Vibration-Controlled Transient Elastography in Liver Transplant Recipients.Clin Gastroenterol Hepatol. 2021 Feb;19(2):367-374. doi: 10.1016/j.cgh.2020.03.067. Epub 2020 Apr 6. Clin Gastroenterol Hepatol. 2021. PMID: 32272251 Free PMC article.
-
Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease.J Gastroenterol Hepatol. 2017 Jul;32(7):1363-1369. doi: 10.1111/jgh.13671. J Gastroenterol Hepatol. 2017. PMID: 27936280
-
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.J Hepatol. 2021 Oct;75(4):770-785. doi: 10.1016/j.jhep.2021.04.044. Epub 2021 May 13. J Hepatol. 2021. PMID: 33991635
-
Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLD.J Clin Exp Hepatol. 2022 Jan-Feb;12(1):174-179. doi: 10.1016/j.jceh.2021.08.002. Epub 2021 Aug 8. J Clin Exp Hepatol. 2022. PMID: 35068797 Free PMC article. Review.
Cited by
-
Machine learning-based disease risk stratification and prediction of metabolic dysfunction-associated fatty liver disease using vibration-controlled transient elastography: Result from NHANES 2021-2023.BMC Gastroenterol. 2025 Apr 14;25(1):255. doi: 10.1186/s12876-025-03850-x. BMC Gastroenterol. 2025. PMID: 40229697 Free PMC article.
-
Association between estimated glucose disposal rate and the risk of MAFLD in American adults: a cross-sectional study.Sci Rep. 2025 Jun 2;15(1):19251. doi: 10.1038/s41598-025-04502-6. Sci Rep. 2025. PMID: 40456932 Free PMC article.
-
Update on the Complications and Management of Liver Cirrhosis.Med Sci (Basel). 2025 Feb 5;13(1):13. doi: 10.3390/medsci13010013. Med Sci (Basel). 2025. PMID: 39982238 Free PMC article. Review.
-
Primary Non-HFE Hemochromatosis: A Review.J Clin Transl Hepatol. 2023 Aug 28;11(4):925-931. doi: 10.14218/JCTH.2022.00373. Epub 2023 Feb 2. J Clin Transl Hepatol. 2023. PMID: 37408807 Free PMC article. Review.
-
Associations between allostatic load and hepatic steatosis and liver fibrosis: evidence from NHANES 2017-2020.BMC Public Health. 2024 Jun 15;24(1):1602. doi: 10.1186/s12889-024-19111-7. BMC Public Health. 2024. PMID: 38879469 Free PMC article.
References
-
- Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68(6):1–77. - PubMed
LinkOut - more resources
Full Text Sources